Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
Investors Business Daily
Wed, 09/18/19 - 09:53 am
Novo Nordisk
Eli Lilly
oral semaglutide
Trulicity
diabetes
EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win
Fierce Pharma
Tue, 09/17/19 - 03:41 pm
Novo Nordisk
Ozempic
JNJ
Invokana
Victoza
diabetes
EASD
Factbox: Britain's insulin providers prepare for Brexit fallout
Yahoo/Reuters
Tue, 09/17/19 - 10:05 am
Novo Nordisk
Eli Lilly
Sanofi
UK
Brexit
insulin
diabetes
Novo Nordisk and Medtronic to integrate diabetes technology
Pharmaforum
Mon, 09/16/19 - 09:20 am
Novo Nordisk
Medtronic
diabetes
devices
blood glucose monitoring
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Wed, 09/11/19 - 11:41 pm
Novo Nordisk
diabetes
ICER
oral semaglutide
Eli Lilly
Boehringer Ingelheim
Jardiance
Ozempic
Novo Nordisk to cut insulin prices for some U.S. diabetics
Yahoo/Reuters
Fri, 09/6/19 - 10:08 am
Novo Nordisk
drug pricing
Novolog
insulin
diabetes
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
BioSpace
Thu, 08/22/19 - 05:01 pm
Novo Nordisk
Mylan
generics
Victoza
diabetes
Novo faces shareholder suit over insulin sales disclosures
Biopharma Dive
Fri, 08/16/19 - 12:54 pm
Novo Nordisk
insulin
investors
Novo Nordisk's new diabetes, obesity drugs lift sales outlook
Yahoo/Reuters
Fri, 08/9/19 - 10:33 am
Novo Nordisk
earnings
Novo extends R&D alliance with AI specialist e-Therapeutics
Pharmaforum
Fri, 08/2/19 - 11:51 pm
Novo Nordisk
R&D
e-therapeutics
artificial intelligence
Novo, e-therapeutics extend Type 2 diabetes research pact to include new genomics tech
Fierce Biotech
Thu, 08/1/19 - 10:35 am
Novo Nordisk
e-therapeutics
drug discovery
type 2 diabetes
New York investigating 3 insulin makers' pricing strategies
Beckers Hospital Review
Tue, 07/30/19 - 11:09 pm
New York
insulin
diabetes
Sanofi
Eli Lilly
Novo Nordisk
Roche and Novo Nordisk Top Clinical Trial Transparency Survey
BioSpace
Fri, 07/19/19 - 10:46 am
Roche
Novo Nordisk
JNJ
clinical trials
clinical trial transparency
Score! 'Good Pharma' ranking finds uptick in new drug data sharing and clinical trial transparency
Fierce Pharma
Wed, 07/10/19 - 07:36 pm
pharma industry
Good Pharma
Novo Nordisk
Roche
clinical trial transparency
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Mon, 07/1/19 - 10:32 am
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Novo Nordisk’s Victoza gets FDA okay for pediatric use
Pharmaforum
Tue, 06/18/19 - 10:10 am
Novo Nordisk
Victoza
type 2 diabetes
pediatric
Novo Nordisk goes for broke on semaglutide heart data
Biopharma Dive
Tue, 06/11/19 - 06:01 pm
Novo Nordisk
diabetes
FDA
Ozempic
oral semaglutide
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Mon, 06/10/19 - 09:27 am
Eli Lilly
ADA
diabetes
heart attack
stroke
Trulicity
Novo Nordisk
semaglutide
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »